Scarica l'app Stockscreener
4.77
2.02%
0.07
Precedente Chiudi:
$4.70
Aprire:
$4.7
Volume 24 ore:
121.66K
Relative Volume:
0.08
Capitalizzazione di mercato:
$11.08M
Reddito:
$15.66M
Utile/perdita netta:
$5.83M
Rapporto P/E:
-0.1996
EPS:
-23.8939
Flusso di cassa netto:
$466.20K
1 W Prestazione:
-1.94%
1M Prestazione:
-69.10%
6M Prestazione:
-2.54%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.61
$5.00
Intervallo di 1 settimana:
$4.36
$5.085
Portata 52W:
$2.90
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Nome
Neuphoria Therapeutics Inc
Settore
Industria
Telefono
781-439-5551
Indirizzo
100 SUMMIT DR, BURLINGTON
Confronta NEUP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
4.76 | 11.08M | 15.66M | 5.83M | 466.20K | -23.89 |
|
ARGX
Argen X Se Adr
|
921.04 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.12 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.76 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
364.07 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.59 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Reiterato | Maxim Group | Buy |
| 2022-01-10 | Iniziato | Berenberg | Buy |
| 2022-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Iniziato | Evercore ISI | Outperform |
| 2022-01-10 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Neuphoria Therapeutics Inc Borsa (NEUP) Ultime notizie
How to read the order book for Neuphoria Therapeutics Inc.Quarterly Trade Review & High Conviction Buy Zone Alerts - newser.com
What Wall Street predicts for Neuphoria Therapeutics Inc. stock price2025 Price Momentum & AI Enhanced Trading Signals - newser.com
Can Neuphoria Therapeutics Inc. stock rebound after recent weaknessJuly 2025 Fed Impact & Precise Buy Zone Tips - newser.com
Is Neuphoria Therapeutics Inc. still worth holding after the dipJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
What does recent volatility data suggest for Neuphoria Therapeutics Inc.July 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Can Neuphoria Therapeutics Inc. stock maintain operating marginsTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
Is Neuphoria Therapeutics Inc. stock attractive after correctionJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
What indicators show strength in Neuphoria Therapeutics Inc.2025 Volatility Report & AI Driven Stock Movement Reports - newser.com
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Neuphoria Therapeutics may offer & sell common stock of up to $20 million from time to timeSEC filing - MarketScreener
Is Neuphoria Therapeutics Inc. meeting your algorithmic filter criteriaQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Neuphoria Therapeutics Inc. stock hit analyst price targetsAnalyst Downgrade & Real-Time Price Movement Reports - Fundação Cultural do Pará
Will Neuphoria Therapeutics Inc. stock deliver shareholder value2025 Analyst Calls & Accurate Entry and Exit Point Alerts - Fundação Cultural do Pará
Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView
Is Neuphoria Therapeutics Inc. showing signs of accumulation2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
Combining price and volume data for Neuphoria Therapeutics Inc.Portfolio Value Report & AI Powered Buy/Sell Recommendations - newser.com
Will Neuphoria Therapeutics Inc. stock attract more institutional investors2025 Valuation Update & Long Hold Capital Preservation Tips - newser.com
What analysts say about Neuphoria Therapeutics Inc stockRSI Overbought/Oversold & Free Smart Trading Classes - earlytimes.in
Neuphoria Files a Preliminary Proxy Statement with Securities and Exchange Commission - MarketScreener
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - Stocktwits
Neuphoria Announces Receipt of Nomination Notice from Lynx1 Master - MarketScreener
Why hedge funds are buying Neuphoria Therapeutics Inc. stockMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value - MSN
Neuphoria announces initiation of strategic review - MarketScreener
Neuphoria Therapeutic (NEUP) Explores Strategic Options and Faces Acquisition Interest - GuruFocus
Neuphoria stock rises after initiating strategic review By Investing.com - Investing.com Canada
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value - Bluefield Daily Telegraph
Neuphoria (NASDAQ: NEUP) receives $5.20/share non-binding interest, engages H.C. Wainwright - Stock Titan
Lynx1 Capital Nominates Candidates to Neuphoria Therapeutics Board - MarketScreener
Neuphoria Therapeutics Inc Azioni (NEUP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.01%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):